Aurora Cannabis Inc COM NPV (OTCMKTS:ACBFF) has recently released a consolidated update on its operations.

Operational Update

Aurora Cannabis CanvasRx, has now aided more than 13,000 patients with Licensed Producers registration. This indicates a significant increase in patient registration since it has been acquired by Aurora Cannabis in August. As of this month, there are over 20 CanvasRx locations in Canada. Five more locations are expected to open before the end of the year.

Moreover, Aurora Cannabis has begun receiving analytical equipment such as gas chromatography mass spectrometry inductively coupled plasma mass spectrometry, ultra-performance liquid chromatography, among others for its onsite laboratory. Upon the approval of the onsite laboratory by Health Canada, it will help the company save massive resources while improving testing and production procedures.

Aurora Cannabis has also boasted about a consistent monthly gross revenue of at least $1 million since July. Earlier this month, the company has recorded its biggest daily sales volume after processing 1,096 transactions of nearly 20,000 grams of marijuana. Furthermore, the week from October 28 to November 3 has seen the biggest seven-day sales performance with over 50 kg of marijuana sold.

“We continue to fire on all cylinders, reaching more patients, continuing to integrate industry-leading technology, and further building our operational capabilities from a position of unprecedented financial strength,” commented Terry Booth, Aurora Cannabis CEO.

Executive Update

Earlier this month, Aurora Cannabis has named Cam Battley, Aurora Cannabis Senior Vice President (SVP) of Communications and Medical Affairs and a Cannabis Canada Board of Directors member, as the new Executive VP (EVP). Battley’s expertise in the pharmaceutical industry is backed by nearly 20 years of global experience.

Speaking of latest appointments in the cannabis industry, Marapharm Ventures COM NPV (OTCMKTS:MRPHF) earlier this months has also named Bradley Dixon as a member of its five-member Management Advisory Group (MAG). The company hopes to tap his expertise in legal counseling as it seeks to execute its long-term growth strategy with the help of the MAG.

Aurora Cannabis has surged 0.50% on Monday, closing at $2.04. On the other hand, Marapharm Ventures has also gained 6.54%, closing at $1.14.